MicroRNA-7704 (miR-7704) has been identified as a potential therapeutic target for acute lung injury (ALI) by promoting M2 macrophage polarization through inhibition of the MyD88/STAT1 signaling pathway [14]. The gene discussed is MYD88; the disease is acute lung injury.